Michael Engsig

Company: Nykode Therapeutics

Job title: Chief Executive Officer

Seminars:

APC-Targeted Vaccines Deliver Antigen Specific Immune Tolerance 2:30 pm

• Latest updates on the development of Nykode's APC-targeted tolerogenic vaccines • Novel pre-clinical PoC and MoA data in autoimmune disease models using different APC-targeting vaccine approaches Read more

day: Custom Day Two

A Hanson Wade Group Company

© Copyright 2025 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.